Compare Vir Biotechnology Inc. Common Stock (VIR) vs Consumer Staples Select Sector SPDR Fund (XLP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vir Biotechnology Inc. Common Stock vs Consumer Staples Select Sector SPDR Fund — how do they compare? Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B), while Consumer Staples Select Sector SPDR Fund trades at $86.91 (market cap $14.15B). The key difference: Consumer Staples Select Sector SPDR Fund is far larger — about 7.9× Vir Biotechnology Inc. Common Stock's market cap, and Consumer Staples Select Sector SPDR Fund is more actively traded (10,004,762 versus 1,782,836). Which is the better fit depends on your goals — on Pluang, investors hold Vir Biotechnology Inc. Common Stock for 0 Days and Consumer Staples Select Sector SPDR Fund for 73 Days on average.
| VIR | XLP | |
|---|---|---|
Market Cap | $1.80B | $14.15B |
Volume | 1,782,836 | 10,004,762 |
Sector | Health | — |
52-Week High | $11.78 | $90.00 |
52-Week Low | $5.12 | $75.61 |
Typical Hold Time | 0 Days | 73 Days |
Enterprise Value | $1.36B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XLP trades at $84.19, down 0.26% on the day, with a bullish technical outlook supported by moving averages and ADX signals. Analyst consensus is unanimously positive with 100% buy ratings. Recent news highlights its competitive expense ratio and defensive appeal amid market volatility, with strong performance relative to discretionary sectors in 2026.
The ETF's low costs and sector resilience underpin a favorable outlook, though overbought RSI levels and interest rate sensitivity pose near-term risks. Institutional favor and dividend stability offer long-term value, but macroeconomic pressures require monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →About Consumer Staples Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as Consumer Staples companies by the GICS®. It is non-diversified.
Read more on XLP →
